Association of the Modified Albumin-Bilirubin Grade with Survival Outcomes in Esophageal Squamous Cell Carcinoma
- PMID: 35527327
- DOI: 10.1245/s10434-022-11679-x
Association of the Modified Albumin-Bilirubin Grade with Survival Outcomes in Esophageal Squamous Cell Carcinoma
References
-
- Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550–8. - DOI
-
- Kuo YH, Wang JH, Hung CH, et al. Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use. J Gastroenterol Hepatol. 2017;32(12):1975–81. - DOI
-
- Ueshima K, Nishida N, Hagiwara S, et al. Impact of baseline albi grade on the outcomes of hepatocellular carcinoma patients treated with lenvatinib: a multicenter study. Cancers (Basel). 2019;11(7):952. - DOI
-
- Imamura T, Okamura Y, Sugiura T, et al. Clinical significance of preoperative albumin-bilirubin grade in pancreatic cancer. Ann Surg Oncol. 2021;28(11):6223–35. - DOI
-
- Koh HH, Cho ES, Lee JH, et al. Association of albumin-bilirubin grade and myosteatosis with its prognostic significance for patients with colorectal cancer. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11445-z . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
